Dolby Laboratories, Inc.
DLB
$65.27
$1.081.68%
NYSE
| 06/26/2026 | 03/27/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -22.91% | 14.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -22.91% | 14.11% | |||
| Cost of Revenue | -9.86% | 3.52% | |||
| Gross Profit | -24.57% | 15.62% | |||
| SG&A Expenses | -6.66% | 6.38% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.91% | 2.34% | |||
| Operating Income | -66.76% | 58.52% | |||
| Income Before Tax | -63.41% | 67.17% | |||
| Income Tax Expenses | -39.83% | 35.29% | |||
| Earnings from Continuing Operations | -69.39% | 77.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -13.54% | -52.26% | |||
| Net Income | -69.87% | 77.99% | |||
| EBIT | -66.76% | 58.52% | |||
| EBITDA | -56.28% | 43.87% | |||
| EPS Basic | -69.55% | 78.45% | |||
| Normalized Basic EPS | -60.81% | 48.33% | |||
| EPS Diluted | -69.70% | 80.00% | |||
| Normalized Diluted EPS | -60.80% | 49.51% | |||
| Average Basic Shares Outstanding | -1.03% | -0.26% | |||
| Average Diluted Shares Outstanding | -1.04% | -1.04% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 2.28% | -0.44% | |||